Cargando…
Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy
BACKGROUND: Although immune checkpoint blockade is effective for several malignancies, a substantial number of patients remain refractory to treatment. The future of immunotherapy will be a personalized approach adapted to each patient’s cancer-immune interactions in the tumor microenvironment (TME)...
Autores principales: | Nagaoka, Koji, Shirai, Masataka, Taniguchi, Kiyomi, Hosoi, Akihiro, Sun, Changbo, Kobayashi, Yukari, Maejima, Kazuhiro, Fujita, Masashi, Nakagawa, Hidewaki, Nomura, Sachiyo, Kakimi, Kazuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583806/ https://www.ncbi.nlm.nih.gov/pubmed/33093158 http://dx.doi.org/10.1136/jitc-2020-001358 |
Ejemplares similares
-
Identification of Neoantigens in Two Murine Gastric Cancer Cell Lines Leading to the Neoantigen-Based Immunotherapy
por: Nagaoka, Koji, et al.
Publicado: (2021) -
Neoantigen Dendritic Cell Vaccination Combined with Anti-CD38 and CpG Elicits Anti-Tumor Immunity against the Immune Checkpoint Therapy-Resistant Murine Lung Cancer Cell Line LLC1
por: Sun, Changbo, et al.
Publicado: (2021) -
Immuno-genomic profiling of biopsy specimens predicts neoadjuvant chemotherapy response in esophageal squamous cell carcinoma
por: Sasagawa, Shota, et al.
Publicado: (2022) -
Integrative immunogenomic analysis of gastric cancer dictates novel immunological classification and the functional status of tumor‐infiltrating cells
por: Sato, Yasuyoshi, et al.
Publicado: (2020) -
CTLs regulate tumor growth via cytostatic effects rather than cytotoxicity: a few T cells can influence the growth of many times more tumor cells
por: Kakimi, Kazuhiro, et al.
Publicado: (2014)